Error loading player: No playable sources found
The Genome Editing Revolution - Translating Genome Editing Technologies into Human Therapies
Free
Standard Price
This product is also available as part of the following products:
Keystone Symposia Live Panel:
The Genome Editing Revolution: Translating Genome Editing Technologies into Human Therapies
Recent advances in genome editing nucleases have led to their broader application in biomedical research and dramatically accelerated efforts to develop therapeutics based on this technology. In this dynamic, interactive panel event, experts in genome editing and gene therapy from academia and industry will discuss the following topics and others relevant to clinical translation of the technology:
- What are the most important recent basic science and technological advances and biggest impacts in the field of genome editing that will substantially advance the prospects of gene-based therapy?
- How can the experiences of the gene therapy field inform the development of genome editing therapeutics?
- What are the risks and biggest obstacles that must be minimized and overcome to successfully translate genome editing into human therapeutics?
- Which diseases are the most promising candidates to benefit from genome editing therapies?
- What impact, if any, has the CRISPR IP dispute had on developing gene-based therapeutics?
___
Copyright Keystone Symposia, 2017. All rights reserved.
About Keystone Symposia:
Keystone Symposia is a 501(c)(3) nonprofit organization founded in 1972 that convenes 50-60 open, international scientific research conferences each year across the full range of the life sciences – from cardiovascular disease to immunology to neurobiology. The conferences accelerate life science discovery by bringing together and fostering collaboration among the world’s leading and next generation of research scientists.
Website: www.keystonesymposia.org
Moderator
J. Keith Joung, MD, Ph.D.
Massachussetts General Hospital
Panelists
Rachel E. Haurwitz, PhD
Caribou Biosciences, Inc.
Michael Holmes, PhD
Sangamo
Alexandra Glucksmann, PhD
Editas Medicine
James M. Wilson, MD, PhD
University of Pennsylvania, Perelman School of Medicine
General
Related Products
Mosquito-Borne Diseases: From Long Time Foes to Emerging Threats
Arboviruses are a large group of viruses transmitted by insects such as mosquitos and ticks…
In vivo Methods to Characterize and Design Regulatory sRNAs in Bacteria
IN VIVO METHODS TO CHARACTERIZE AND DESIGN REGULATORY SRNAS IN BACTERIA
Health Disparities: Sickle Cell, Research and CRISPR
About 100,000 people in the United States have sickle cell disease, with most of the patient population derived from communities of African descent…
Drug Discovery: Current Trends in Medicinal Chemistry
DRUG | _DRƏꞬ_ | NOUN: A MEDICINE OR OTHER SUBSTANCE WHICH HAS A PHYSIOLOGICAL EFFECT WHEN INGESTED OR OTHERWISE INTRODUCED INTO THE BODY
